Verastem, Inc. Notes Payable, Current
Verastem, Inc. (VSTM) had Notes Payable, Current of $214.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:NotesPayableCurrent · last filed 2026-08-06
- 2026-06-30: Notes Payable, Current $214.00K.
- 2026-03-31: Notes Payable, Current $529.00K.
- 2025-09-30: Notes Payable, Current $188.00K.
- 2025-06-30: Notes Payable, Current $467.00K.
| Period end | Notes Payable, Current |
|---|---|
| 2026-06-30 | $214.00K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $529.00K 10-Q · filed 2026-05-07 |
| 2025-09-30 | $188.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $467.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $740.00K 10-Q · filed 2025-05-13 |
| 2024-09-30 | $133.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $526.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $911.00K 10-Q · filed 2024-05-09 |
| 2023-09-30 | $146.00K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $579.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.00M 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |